News Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 15/01/2026 GMT			Pre-market 11:51:41
90.03 ^USD	-3.96%		89.60	-0.47%

09:03am	RTW Biotech's portfolio firm Penumbra acquired by Boston Scientific	AN
01-15	Health Care Down Amid Mixed Earnings -- Health Care Roundup	DJ

09:03am	RTW Biotech's portfolio firm Penumbra acquired by Boston Scientific	AN
01-15	Health Care Down Amid Mixed Earnings -- Health Care Roundup	DJ
01-15	Wall Street Snaps 2-Day Losing Streak as Semiconductors Shine, Bank Stocks Rise	MT
01-15	Sector Update: Health Care Stocks Softer Late Afternoon	MT
01-15	Semiconductor, Bank Stocks Help Lift Equity Markets Intraday	MT
01-15	Sector Update: Health Care Stocks Softer in Afternoon Trading	MT
01-15	Sector Update: Health Care	MT
01-15	Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	MT
01-15	Sector Update: Health Care	MT
01-15	Strong Chipmaker Earnings Lift Technology Sector, With US Equity Futures Mostly Higher Pre-Bell	MT
01-15	Boston Scientific to Acquire Penumbra in $14.5 Billion Deal	MT
01-15	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Buoyed by Taiwan Semiconductor Manufacturing Guidance	MT
01-15	Top Premarket Decliners	MT
01-15	Boston Scientific to Acquire Penumbra in $14.5 Billion Cash-Stock Deal	MT
01-15	Boston Scientific to Buy Penumbra in Deal Reflecting $14.5 Billion Enterprise Value	MT
01-15	Boston Scientific to Acquire Penumbra in Deal Reflecting $14.5 Billion Enterprise Value	MT
01-15	Boston Scientific Corporation, Penumbra, Inc. - M&A Call
01-15	Boston Scientific Corporation entered into a definitive agreement to acquire Penumbra, Inc. for $14.8 billion.	CI
01-15	Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- 2nd Update	DJ
01-15	Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- Update	DJ
01-15	Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock	DJ
01-15	Boston Scientific announces agreement to acquire Penumbra	RE
01-15	Top alert-Boston Scientific announces agreement to acquire Penumbra, Inc.	RE
01-15	Boston Scientific beefs up heart device portfolio with $14.5 billion Penumbra deal	RE
01-13	Boston Scientific Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 09:00 AM

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Boston Scientific exceeds analysts' estimates for seven straight quarters

June 26, 2025 at 10:04 am